These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 20370586

  • 1. Noninvasive fetal RhD genotyping from maternal blood.
    Kolialexi A, Tounta G, Mavrou A.
    Expert Rev Mol Diagn; 2010 Apr; 10(3):285-96. PubMed ID: 20370586
    [Abstract] [Full Text] [Related]

  • 2. RHD genotyping from maternal plasma: guidelines and technical challenges.
    Avent ND.
    Methods Mol Biol; 2008 Apr; 444():185-201. PubMed ID: 18425481
    [Abstract] [Full Text] [Related]

  • 3. Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects.
    Daniels G, Finning K, Martin P, Massey E.
    Prenat Diagn; 2009 Feb; 29(2):101-7. PubMed ID: 19085963
    [Abstract] [Full Text] [Related]

  • 4. The use of maternal plasma for prenatal RhD blood group genotyping.
    Finning K, Martin P, Daniels G.
    Methods Mol Biol; 2009 Feb; 496():143-57. PubMed ID: 18839110
    [Abstract] [Full Text] [Related]

  • 5. Fetal RhD genotyping by analysis of maternal blood. A case report.
    Tóth T, Papp C, Tóth-Pál E, Nagy B, Papp Z.
    J Reprod Med; 1998 Mar; 43(3):219-22. PubMed ID: 9564650
    [Abstract] [Full Text] [Related]

  • 6. Fetal blood group genotyping: present and future.
    Daniels G, Finning K, Martin P, Summers J.
    Ann N Y Acad Sci; 2006 Sep; 1075():88-95. PubMed ID: 17108196
    [Abstract] [Full Text] [Related]

  • 7. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.
    van der Schoot CE, Tax GH, Rijnders RJ, de Haas M, Christiaens GC.
    Transfus Med Rev; 2003 Jan; 17(1):31-44. PubMed ID: 12522770
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Prenatal genotyping of the RhD locus by polymerase chain reaction in fetus at risk of hemolytic disease].
    Misković B, Stipoljev F, Hadzisejdić I, Grahovac B.
    Lijec Vjesn; 2008 Jan; 130(1-2):4-6. PubMed ID: 18589635
    [Abstract] [Full Text] [Related]

  • 10. Fetal RhD genotyping: a more efficient use of anti-D immunoglobulin.
    Daniels G, Finning K, Martin P, Summers J.
    Transfus Clin Biol; 2007 Dec; 14(6):568-71. PubMed ID: 18436463
    [Abstract] [Full Text] [Related]

  • 11. [Genetic analysis of the fetus using maternal blood].
    Costa JM, Gautier E, Benachi A.
    Gynecol Obstet Fertil; 2004 Dec; 32(7-8):646-50. PubMed ID: 15450264
    [Abstract] [Full Text] [Related]

  • 12. [Fetal RHD genotyping by PCR using plasma from D negative pregnant women].
    Achargui S, Tijane M, Benchemsi N.
    Transfus Clin Biol; 2011 Feb; 18(1):13-9. PubMed ID: 21190884
    [Abstract] [Full Text] [Related]

  • 13. Noninvasive fetal RHD genotyping from maternal plasma. Use of a new developed Free DNA Fetal Kit RhD.
    Rouillac-Le Sciellour C, Sérazin V, Brossard Y, Oudin O, Le Van Kim C, Colin Y, Guidicelli Y, Menu M, Cartron JP.
    Transfus Clin Biol; 2007 Dec; 14(6):572-7. PubMed ID: 18375165
    [Abstract] [Full Text] [Related]

  • 14. Noninvasive prenatal RHD genotyping by real-time polymerase chain reaction using plasma from D-negative pregnant women.
    Zhou L, Thorson JA, Nugent C, Davenport RD, Butch SH, Judd WJ.
    Am J Obstet Gynecol; 2005 Dec; 193(6):1966-71. PubMed ID: 16325598
    [Abstract] [Full Text] [Related]

  • 15. Noninvasive fetal RHD genotyping by maternal plasma with capillary electrophoresis.
    Kimura M, Sato C, Hara M, Ishihara O, Ikebuchi K.
    Transfusion; 2008 Jun; 48(6):1156-63. PubMed ID: 18422850
    [Abstract] [Full Text] [Related]

  • 16. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.
    Müller SP, Bartels I, Stein W, Emons G, Gutensohn K, Köhler M, Legler TJ.
    Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461
    [Abstract] [Full Text] [Related]

  • 17. Molecular analysis of the RhD genotype in fetuses at risk for RhD hemolytic disease.
    Spence WC, Maddalena A, Demers DB, Bick DP.
    Obstet Gynecol; 1995 Feb; 85(2):296-8. PubMed ID: 7824249
    [Abstract] [Full Text] [Related]

  • 18. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma.
    Hromadnikova I, Vechetova L, Vesela K, Benesova B, Doucha J, Kulovany E, Vlk R.
    Fetal Diagn Ther; 2005 Feb; 20(4):275-80. PubMed ID: 15980640
    [Abstract] [Full Text] [Related]

  • 19. Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies.
    Hromadnikova I, Vechetova L, Vesela K, Benesova B, Doucha J, Vlk R.
    J Histochem Cytochem; 2005 Mar; 53(3):301-5. PubMed ID: 15750007
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood--a meta-analysis.
    Geifman-Holtzman O, Grotegut CA, Gaughan JP.
    Am J Obstet Gynecol; 2006 Oct; 195(4):1163-73. PubMed ID: 17000250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.